Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil M deGoma

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|January 5, 2008
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterolEmil M deGoma, Nicholas J Leeper, Paul A Heidenreich
Journal of the American College of Cardiology|June 7, 2008
Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approachesEmil M deGoma, Rolando L deGoma, Daniel J Rader
Atherosclerosis|January 26, 2013
Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equationsEmil M deGoma, Richard L Dunbar, Douglas Jacoby, et al.
Journal of Clinical Lipidology|June 16, 2015
Updated cholesterol guidelines and intensity of statin therapyVincent Nguyen, Emil M deGoma, Erik Hossain, et al.
Circulation|August 1, 2007
Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survivalNicholas J Leeper, Reza Ardehali, Emil M deGoma, et al.
Journal of the American College of Cardiology|December 19, 2006
Emerging therapies for the management of decompensated heart failure: from bench to bedsideEmil M deGoma, Randall H Vagelos, Michael B Fowler, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|August 31, 2010
The underappreciated impact of heart diseaseEmil M deGoma, Ronald P Karlsberg, Debra R Judelson, et al.
Journal of Clinical Lipidology|December 3, 2010
Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese familyEmil M deGoma, Matthew T Wheeler, Santica M Marcovina, et al.
Cardiology in Review|December 21, 2011
The evolution and refinement of traditional risk factors for cardiovascular diseaseEmil M deGoma, Joshua W Knowles, Fabio Angeli, et al.
American Journal of Nephrology|March 27, 2017
Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney DiseaseEdouard R Martin, Mark T Smith, Bradley J Maroni, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|January 5, 2008
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterolEmil M deGoma, Nicholas J Leeper, Paul A Heidenreich
Journal of the American College of Cardiology|June 7, 2008
Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approachesEmil M deGoma, Rolando L deGoma, Daniel J Rader
Atherosclerosis|January 26, 2013
Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equationsEmil M deGoma, Richard L Dunbar, Douglas Jacoby, et al.
Journal of Clinical Lipidology|June 16, 2015
Updated cholesterol guidelines and intensity of statin therapyVincent Nguyen, Emil M deGoma, Erik Hossain, et al.
Circulation|August 1, 2007
Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survivalNicholas J Leeper, Reza Ardehali, Emil M deGoma, et al.
Journal of the American College of Cardiology|December 19, 2006
Emerging therapies for the management of decompensated heart failure: from bench to bedsideEmil M deGoma, Randall H Vagelos, Michael B Fowler, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|August 31, 2010
The underappreciated impact of heart diseaseEmil M deGoma, Ronald P Karlsberg, Debra R Judelson, et al.
Journal of Clinical Lipidology|December 3, 2010
Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese familyEmil M deGoma, Matthew T Wheeler, Santica M Marcovina, et al.
Cardiology in Review|December 21, 2011
The evolution and refinement of traditional risk factors for cardiovascular diseaseEmil M deGoma, Joshua W Knowles, Fabio Angeli, et al.
American Journal of Nephrology|March 27, 2017
Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney DiseaseEdouard R Martin, Mark T Smith, Bradley J Maroni, et al.
Pageof 4